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Abstract
Background
The use of long-acting reversible contraceptive (LARC) methods is very low in Pakistan
with high discontinuation rates mainly attributed to method-related side effects. Mixed evi-
dence is available on the effectiveness of different client follow-up approaches used to
ensure method continuation. We compared the effectiveness of active and passive follow-
up approaches in sustaining the use of LARC—and within ‘active’ follow-up, we further com-
pared a telephone versus home-based approach in rural Punjab, Pakistan.
Methods
This was a 12-month multicentre non-inferiority trial conducted in twenty-two (16 rural- and
6 urban-based) franchised reproductive healthcare facilities in district Chakwal of Punjab
province, between November 2013 and December 2014. The study comprised of three
groups of LARC clients: a) home-based follow-up, b) telephone-based follow-up, and c)
passive or needs-based follow-up. Participants in the first two study groups received coun-
selling on scheduled follow-up from the field workers at 1, 3, 6, 9, and 12 month post-inser-
tion whereas participants in the third group were asked to contact the health facility if in
need of medical assistance relating to LARCmethod use. Study participants were recruited
with equal allocation to each study group, but participants were not randomized. The analy-
ses are based on 1,246 LARC (intra-uterine contraceptive device and implant) users that
completed approximately 12-months of follow-up. The non-inferiority margin was kept at
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five percentage points for the comparison of active and passive follow-up and six percent-
age points for telephone and home-based approach. The primary outcome was cumulative
probability of method continuation at 12-month among LARC users.
Results
Women recruited in home-based, telephone-based, and passive groups were 400, 419 and
427, respectively. The cumulative probability of LARC continuation at 12 month was 87.6%
(95% CI 83.8 to 90.6) among women who received home-based follow-up; 89.1% (95% CI
85.7, 91.8) who received telephone-based follow-up; and 83.8% (95% CI 79.8 to 87.1) who
were in the passive or needs-based follow-up group. The probability of continuation among
women who were actively followed-up by field health educators—either through home-
based visit or telephone-based follow-up was, 88.3% (95% CI 85.9 to 90.0). An adjusted
risk difference of -4.1 (95% CI -7.8 to -0.28; p-value = 0.035) was estimated between active
and passive follow-up. Whereas, within the active client follow-up, the telephone-based fol-
low-up was found to be as effective as the home-based follow-up with an adjusted risk dif-
ference of 1.8 (95% CI -2.7 to 6.4; p-value = 0.431).
Conclusion
A passive follow-up approach was 5% inferior to an active follow-up approach; whereas
telephone-based follow-up was as effective as the home-based visits in sustaining the use
of LARC, and was far more resource efficient. Therefore, active follow-up could improve
method continuation especially in the critical post-insertion period.
Introduction
Galvanised by the Millennium Development Goals (MDGs), many countries have achieved
success in meeting demand for family planning (FP)[1,2]. Nonetheless, while making efforts to
expand access for family planning, it is equally important to take into account the factors that
reduce contraceptive prevalence rates such as contraceptive side-effects, method failure, dis-
continuation, and switching which may have negative consequences on health outcomes[3,4].
These issues are of critical importance for couples and for the programmes and policies that
aim to improve sexual and reproductive health[3].
The 2015 demographic health survey (DHS) analyses of lower-income countries show that,
within the first year of use, 9 percent of women discontinue using contraceptive implants, 15
percent discontinue IUDs, and 32 percent discontinue injectables. While these rates are lower
than the 40 percent of women who discontinue non-LARC modern methods in the first year
[5], but these rates are still unacceptably high. The most common reason for discontinuation
(for all contraceptives) is reported to be method related side-effects and health concerns fol-
lowed by inconvenience, and desire for a more effective method[3,5].
Generally, in community-based interventions, the home-based visits by community health
workers (CHWs) are linked to improved maternal and new born health outcomes[6]. Similarly,
in the context of family planning, good counselling and follow-up services may improve adop-
tion of contraceptives, continuation and switching behaviours[7–11]. However, research stud-
ies have shown mixed results regarding the different follow-up approaches (scheduled,
unscheduled, clinic based or telephone-based) used to ensure continuation rates of short- and
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implementing organization; however, they neither
come under nor are part of program team. The study
was conceptualized and conducted by them
independently without any consultation with the
implementing field team.
long-acting family planning methods in different settings[12–15]. For example, higher fre-
quency of scheduled follow-up visits (6 weeks, 3, 6, and 12 months after IUCD insertion) was
found to not be effective in preventing discontinuation, pregnancies and expulsion. In another
setting, telephonic interaction between staff and teenage FP users showed no effect on regular-
ity of contraceptive use and pregnancy rates.
Pakistan, which is currently the sixth most populated country in the world, has had limited
achievements in managing population growth–contraceptive use in particular has remained
stagnant[16–18]. The most commonly used methods are condoms (8.8%), followed by female
sterilisation (8.7%) and withdrawal (8.5%) whereas the use of long-acting reversible contracep-
tive is negligible (2.3%) and has remained unchanged between the 2006–07 and 2012–13 DHS
surveys[16]. According to the latest DHS, 37% of women in Pakistan discontinue the use of
any method within 12 months whereas IUD related discontinuation rate stands at 25%. The
most prominent reason for discontinuation of IUD is side-effects (64%)[16]. Two other key
obstacles that deter women to use all contraceptive methods, are husband’s opposition and
social or cultural unacceptability[19].
Rationale
Marie Stopes Society (MSS), an affiliate of Marie Stopes International in Pakistan, imple-
mented a research study which aimed at promoting the use of modern contraception [espe-
cially long-acting reversible contraceptive (LARC)] by social franchising of private health
providers and providing vouchers to the communities that these health facilities serve[20]. As
part of this intervention, a community health worker [designated as Field Health Educator
(FHE)] is responsible to raise awareness of family planning in the community and provide fol-
low-up for clients for side-effect management. A single FHE would cover a population of
around 20,000–25,000 spread over a 3–6 kilometre radius[20]. The role of the FHE is similar to
that of both Lady Health Workers (LHW) and Community Midwives (CMW). LHWs provide
needs based home visits for a population of 1,000 people, and CMWs provide needs based
home visits for maternal, new born and child health for a population of between 5–6,000 peo-
ple. Both the LHW and CMW programmes are run by the Government of Pakistan[21,22].
The role of FHE is confined to family planning as opposed to LHW and CMWs, the catchment
population of FHE is still notably higher than that of LHWs and CMWs, which can make it
challenging for her to pay routine household visits to all potential clients[23]. We therefore
hoped to first test the assumption that a passive follow-up approach, which is much less
resource intensive, is not inferior to active follow-up for method continuation. The saved
resources could otherwise be used to focus on finding women with unmet need or to attend to
other contraceptive needs of women. Moreover, given the increasing number of mobile phones
in the country (120 million users[24] and 87% household possess a mobile phone[16]), which
is pervasive across all sections of society, we considered testing the effectiveness of using this
technology, compared to the resource intensive home-based follow-up visits.
Research Questions
We conducted this study to address two research questions: firstly, whether a passive or needs-
based follow-up is as effective as an active (active defined as home-based or telephone-based)
follow-up in sustaining method continuation among LARC users. Secondly, whether or not
telephone-based follow-up is as effective as physical home-based follow-up (gold standard) in
sustaining method continuation among LARC users.
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Materials and Methods
Study design and settings
This 12-month multicentre non-inferiority trial was embedded within a larger community-
based experimental study[25]. The larger study aimed to evaluate the effectiveness of demand-
side financing approaches in promoting the use of modern contraceptive methods[20]. We
conducted this non-inferiority trial at 20 selected franchised reproductive healthcare facilities
from a total of 22. Two facilities were excluded due to very low LARC client flow. Of the 20
selected healthcare facilities, 15 (led by mid-level provider) were based in rural areas and 5 (led
by medical doctor) were based in peri-urban areas in Chakwal district of Punjab province in
Pakistan. This study was implemented between November 2013 and December 2014 including
a five month recruitment period. The final follow-up interview was conducted in December
2014, as this was when the larger study concluded. Hence, participants had a varied follow up
period ranging from approximately 9 months to a maximum of 14 months–while mean dura-
tion of participants being in the study was 12 months (see Table 1).
Follow-up approaches and intervention
The study comprised of three groups based on the stated approaches used for clients follow-up:
a) home-based follow-up; b) telephone-based follow-up; and c) passive or needs-based follow-
up. The clients recruited under category ‘a’ received a scheduled follow-up visit at their house-
hold by an FHE at 1, 3, 6, 9, and 12 months. Similarly, clients recruited under category ‘b’
received a telephone call from their FHE at a scheduled frequency similar to category ‘a’. More-
over, clients in both of these categories could also seek medical advice from their FHE or ser-
vice providers based on need (unscheduled contact, either by phone or more usually in-person
as service providers do not usually share contact details with clients). The clients recruited
under ‘passive or needs-based follow-up’ did not receive any scheduled intervention from an
FHE but could seek assistance from an FHE or service provider in the case of a medical need
such as a suspected pregnancy, medical problem, method complication, or desire to remove
their IUCD and/or implant. Categories ‘a’ and ‘b’ were considered as the active group whereas
category ‘c’ was considered as the passive group. During scheduled and unscheduled contacts
FHEs provided counselling to participants on side-effect management based on an adapted
manual used in the Family Advancement for Life and Health (FALAH) project[26]. FHEs were
reimbursed for household visits and telephone call expenses.
Sampling strategy
In order to test non-inferiority between passive and active (household + telephone) groups, a
sample of 1,262 was estimated by keeping the non-inferiority margin of 5 percentage points
difference in cumulative probability of LARC use at 12 month, with 80% power, and 0.05 level
of significance. The sample was equally distributed across the three study groups. As we had to
Table 1. Number and percentage distribution of participants by study duration.
Duration in the study (months) Number of participants Percentage
>9–10 97 7.8
>10–12 622 49.9
>12–13 451 36.2
>13–14 76 6.1
Total 1246 100.0
doi:10.1371/journal.pone.0160683.t001
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omit the needs-based group for testing non-inferiority between telephone and home-based
approaches, the non-inferiority margin was estimated slightly higher at 6 percentage points
while holding other parameters constant. The sample calculation was performed using PASS
version 11.0.
During the conceptualisation phase, preliminary data collected at the study sites through
FHEs revealed that 40% of LARC users had access to either their own or their husbands’mobile
phone. Hence, participants were not randomised to study groups for a number of reasons—
stemming from the low proportion of LARC users with access to phones. Since this trial was
nested within a larger study, and thus had to conform to the larger trials budget and time
frames, it was not possible to double the time frame and only recruit phone owners to allow for
random allocation of study participants32. We enrolled a total of 1,261 women aged 15–49
years, employing a consecutive sampling technique, who received long-acting reversible con-
traceptive (intra-uterine device or implant) methods from the study sites and residing in the
demarcated catchment area. It is pertinent to note that as per national health policy, implant
insertion and/or removal services were only provided at urban-based health facilities that were
led by a medical doctor where IUCD services were available at all selected health facilities. The
LARC sample was equally distributed across all 22 study sites and it took approximately five
months to recruit the desired sample. Prior to enrolment, participants were provided with
study details and asked to voluntarily choose one of the three groups and to sign a written
informed consent form. Clients who didn’t have access to mobile phones were given options to
either join the passive group or the home based follow up group. Moreover, upon the achieve-
ment of the desired sample in any specific group–the group was eliminated as an option for
subsequent clients. To keep a track of enrolment numbers service providers were given stan-
dard templates, where basic demographic and follow up data only was collected. While receiv-
ing their contraceptive method, all the study participants were provided standard counselling
by the service providers regarding contraceptive method, including their effectiveness, possible
side effects, risks and benefits, and what to do or where to go in case of experiencing any side
effect32. Table 2 presents participants’ enrolment and response rate at the end of study.
Data Collection
At baseline (Day 0 interview at the time of recruitment), we collected information on partici-
pant’s demographic and reproductive history, fertility intentions, source of information about
service providers, reasons for choosing LARC and information provided by the service pro-
vider regarding method received. At the 12-month follow-up interview, participants were
asked if they were still using the same contraceptive method, or if they had stopped using it. All
study participants were asked about side effect experiences. In addition, participants who
reported method discontinuation were asked about the reasons for discontinuation, place of
Table 2. Participant’s enrolment and response rate at 12 month.
Participants’ enrolment
Active follow-up group Passive or needs-based follow-up group
Home-based Telephone-based
Baseline interviews 409 424 428
Follow-up interviews at 12 month 400 419 427
Participants’ response rate at end of study: % 97.8% 98.8% 99.8
Cumulative continuation at 12 montha 351/400 (87.8%) 369/419 (88.1%) 358/427 (83.8%)
a unweighted cumulative continuation probability
doi:10.1371/journal.pone.0160683.t002
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IUCD/implant removal, whether they switched to another contraceptive method. Finally, par-
ticipants were also asked about their level of satisfaction with the services, counselling sessions
conducted by FHEs during household visits and telephone contact with clients. To minimize
bias, the interviews at 12 months were conducted by newly hired enumerators, who were
trained to administer the questionnaire by the research team, rather than the FHEs who con-
ducted the baseline data collection. We made three attempts to contact the participant for
12-month follow-up interviews; the participant was considered lost to follow-up, if all attempts
of tracing the client failed. Data was captured on paper forms during face-to-face interviews
and later double-entered in EpiData version 3.1.
Statistical Analysis
We performed statistical analyses with the use of Stata software, version 11.2 (StataCorp. 2009.
Stata Statistical Software: Release 11. College Station, TX: StataCorp LP.). The level of signifi-
cance (alpha) was set at 0.05. We used means, standard deviations, frequencies, and percent-
ages to describe the demographic characteristics of study participants. One-way ANOVA and
chi-square test were performed for continuous and categorical data, respectively. Women in
the active and passive groups were excluded from the analysis if they were lost to follow-up at
the 12-month visit for missing the primary endpoint variable.
To test the hypotheses, risk differences with 95% CIs were calculated for the primary end-
point using a binomial model (generalized binary regression technique) with an identity link.
Given the non-random allocation of participants to the study groups, we estimated adjusted
risk differences to account for possible differences in sample characteristics such as women’s
age, number of children, women’s and husband’s education, type of contraceptive method,
decision for method uptake (self or jointly with others), side effect experiences (yes/no), and
duration (in months) of participation in the study (>9–10,>10–12,>12–13,>13–14). The
intention-to-treat population was all LARC users with data for the primary outcome except for
those who withdrew consent to participate. The per-protocol population was the intention-to-
treat population excluding women who had major protocol violations (e.g. crossover in assess-
ment method). In this study, as no violation of protocol was reported, intention-to-treat analy-
sis was used. Robust standard errors were estimated to account for clustering effect and
possible correlation among participants receiving services from same health facilities. Finally,
because the sample was equally distributed across study sites, we used weights to account for
varying client flow.
Ethical consideration. All respondents were informed about follow-up procedure and
their study rights. No personal information was entered in the database that could be used to
identify specific individual. The study protocol was approved by National Bioethics Committee
(NBC) Pakistan. Ref: No. 4-87/12/NBC-92/RDC/3548 before recruitment was initiated27, 32.
All survey participants provided written informed consent.
Results
Characteristics of the participants
Characteristics of the study participants are presented in Table 3 for each of the study groups
separately. Overall, most of the characteristics were similar across all three groups except for
women’s age, age of last child, and type of method use. The mean age of participants was 31
years with three living children. With regard to health behaviours, nearly half of study partici-
pants used a contraceptive method in the last 3 months prior to receiving LARC. The average
travel time to the health facility was 30 minutes and approximately 98% received LARC
through vouchers. No significant differences were observed in any of these health behaviours.
Comparison of Follow-Up Approaches to Sustain LARC Use
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Participants’ health seeking behaviours and satisfaction with services
Table 4 describes the follow up information of the study participants. Approximately one in
four women reported to have experienced side effects across all three study groups. Among
those, ‘bleeding’ and ‘pain’ were the most common side effects experienced by LARC users.
More specifically, bleeding was comparatively higher (45.5%) in the home-based group as
opposed to 37% (approximately) in other two groups. On the contrary, 21.1% of participants
in the passive group reported pain, followed by 14.9% in telephonic group and 12.5% in home-
based. Moreover, of those who experienced side effects over 75% sought medical assistance for
the treatment. Nearly 75% of women, who chose to have their IUCD/implant removed, in the
active group received removal services from study providers compared to 52% in the passive
group. The results also showed some suggestion (p = 0.0853) that clients who were followed up
were also more likely to switch to another method in the case of discontinuation with 23.2% of
the discontinuers in the passive group switching to another method compared to 30.8% and
43.0% in the home and telephone based groups.
Reports of satisfaction with different aspects of services were very high across all three
groups. Additional questions were asked to the participants that belonged to the active group
regarding follow-up mechanism. Among women groups who received either a home-based
visit or a telephone call, a very high percentage of the participants expressed satisfaction
Table 3. Characteristics of study participants according to study group.
Characteristics Home-based follow
up
Telephone-based follow
up
Passive or needs-based
follow up
p-value
n = 400 n = 419 n = 427
% (SD) % (SD) % (SD)
Age of women in years 0.03
Mean (SD) 31.0 (4.8) 30.3 (4.7) 31.1 (5.1)
Number of living children 0.20
Mean (SD) 3.3 (1.5) 3.1 (1.6) 3.2 (1.5)
Women’s education 0.49
Illiterate 42.4 39.5 47.2
Literate 57.6 60.5 52.9
Husband’s education 0.38
Illiterate 17.5 18.4 21.5
Literate 82.5 81.6 78.5
Age of last child in yearsa 0.01
Mean (SD) 2.7 (2.7) 3.2 (2.7) 3.0 (2.8)
Status of contraceptive use during last 3 months prior to
insertion
0.08
Yes 38.0 54.9 54.9
No 62.1 45.1 45.1
Travel time to study facility (in mins)b 0.21
Mean (SD) 31.1 (21.5) 28.7 (17.9) 29.8 (17.4)
Type of method used <0.001
Implant 8.7 22.8 12.1
IUCD 91.4 77.2 87.9
Missing values
a10
b68
doi:10.1371/journal.pone.0160683.t003
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Table 4. Follow up information and level of satisfaction with the services among study participants by study groups.
Characteristics Home-
based
Telephone-
based
Passive or needs-
based
p-value
n = 400 n = 419 n = 427
% % %
Decision making for method uptake 0.006
Self 32.4 43.7 37.9
Jointly with others 67.6 56.3 62.1
Side effect experiences 0.704
No 75.9 74.1 73.2
Yes 24.1 25.9 26.8
Type of side effect experiences 0.780
Pain 12.5 14.9 21.1
Itching 5.3 8.7 9.6
Bleeding 45.3 36.8 37.4
Sensation of disturbance at the place of insertion 8.7 8.4 9.4
Weight gain 11.9 11.4 5.6
Infection 7.4 8.5 8.6
Others 8.9 11.3 8.3
Seeking medical help for treatment of side effect (amongst those who
experienced side effects)
0.672
Yes 78.4 80.5 75.3
Not received or no need for medical treatment 21.6 19.5 24.7
Reason for method discontinuation 0.067
Pregnancy desire 31.4 31.9 28.2
Expulsion 6.9 1.8 3.2
Opposed by husband and/or in-laws 12.2 2.9 26.7
Side effects 31.0 45.4 26.0
Others 18.4 18.0 15.9
Place of getting IUCD/implant removal services 0.008
Study franchised provider 76.6 77.5 51.9
Public sector provider 11.4 8.6 32.9
Other private 5.1 12.1 12.0
Expulsion 6.9 1.8 3.2
Method switching post IUCD/implant removal 0.0853
Yes 30.8 43.0 23.2
No 69.2 57.0 76.8
Satisfaction
Would recommend service to others 92.9 92.8 88.9 0.0576
Would recommend provider to others 97.7 97.6 94.5 0.0170
Provider attitude 99.7 98.4 98.2 0.1129
Follow-up care 95.4 96.8 85.4 <0.001
Feedback about follow-up mechanism (active group only)
Comfortable receiving visits/calls from FHE 99.7 98.1 - 0.0651
Visit/Call timing was convenient to women 99.7 99.3 - 0.9607
Women consulted by FHE to set convenient time for follow-up 91.4 81.7 - 0.0003
Time spent by FHE (phone or in-person) was adequate 99.1 98.6 - 0.5101
Satisﬁed with the information provided by FHE 99.1 98.0 - 0.1943
Information provided by FHE was found to be useful 93.1 90.8 - 0.0646
doi:10.1371/journal.pone.0160683.t004
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receiving follow-up visits from FHE, timing of visits, time spent by FHE for counseling, and
satisfaction with information received and its use. Satisfaction levels were slightly lower
amongst those in the passive follow up group compared to active. 89% and 95% of women in
the passive follow up group reported that they would recommend the service and provider to
others respectively. This compares to 93% and 98% in the active follow up groups. The only
noticeable difference in satisfaction between women in the telephone-based vs home based fol-
low up group was that 81.7% of women in the telephone based group reported that they were
consulted to set a convenient time for follow-up compared with home-based group (91.4%),
and 93.1% of women in the home-based follow up group found that the information that the
FHE gave them was adequate compared to 90.8% in the telephone group.
Impact of follow-up approaches on method continuation
The cumulative probability of LARC continuation at 12 month was 87.6% (95% CI 83.8 to
90.6) among women who received home-based follow-up, 89.1% (95% CI 85.7, 91.8) who
received telephone follow-up, and 83.8% (95% CI 79.8 to 87.1) who were in the passive or
needs-based follow-up group. The probability of continuation among women who were
actively followed-up by field health educators—either through home-based visit or telephone
call was 88.3% % (95% CI 85.9 to 90.0). The mean length of LARC use before removal was 8.0,
6.5 and 7.1 months in home-based, telephone-based, and passive groups respectively. An
adjusted risk difference of -4.1 (95% CI -7.8 to -0.28; p-value = 0.035) was estimated between
active and passive follow-up which clearly shows significant inferiority of passive follow-up rel-
ative to active follow-up in sustaining the use of LARC. In addition, within active client follow-
up approaches, the telephone-based follow-up was found to be as effective as home-based fol-
low-up (adjusted risk difference 1.8 (95% CI -2.7 to 6.4; p-value = 0.431) (Table 5). On an aver-
age, via telephone, it took 1 (SD 0.2) attempts to contact the client for follow-up counselling.
The average talk time was 3.7 minutes (SD ± 2.4) with a maximum talk time of 20 minutes
(results not shown)
Discussion
In this non-inferiority study, the data showed that the passive follow-up approach is signifi-
cantly inferior, by 5.0%, to active follow-up in sustaining the use of LARC. Moreover, within
Table 5. Crude and adjusted risk differences of LARC continuation at 12 months between active and passive follow-up and home-based versus
telephone-based approaches.
Client follow-up approaches Cumulative probability of continuation at
12-months
Crude risk
difference
Adjusted1risk
difference
(95% CI) (95% CI) (95% CI)
Active versus passive comparison
Passive or needs-based follow-up 83.8 (79.8–87.1) -4.6 (-9.2, -0.01)* -4.1 (-7.8, -0.28)*
Active group (home-based + telephone-based)
follow-up (ref)
88.3 (85.9–90.0) - -
Telephone-based versus home-based
Telephone-based follow-up 89.1 (85.7–91.8) 1.5 (-3.4, 6.4) 1.8 (-2.7, 6.4)
Home-based follow-up (ref) 87.6 (83.8–90.6) - -
* Superiority p-value: <0.05
1 Adjusted for women’s age, number of children, women’s and husband education, type of contraceptive method, decision for method uptake, side effect
experiences, and duration (in months) of participation in the study
doi:10.1371/journal.pone.0160683.t005
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the two active client follow-up approaches—our findings indicated that telephone-based fol-
low-up works equally well to encourage LARC continuation as does home-based (gold stan-
dard) follow-up. The findings are not consistent with the earlier research conducted
specifically to improve IUD continuation in the Netherlands[13]; however, it is pertinent to
note that the setting, procedure and frequency of follow up was different in the two studies.
The overall discontinuation rate in this study at 12 months was considerably lower than the
national average[16] which may be attributed to the overall higher quality of care at the fran-
chised clinics where services were provided under controlled research settings and rigorous
monitoring. Also, the national data is a reflection of the behaviour of both public and private-
sector users. The findings on discontinuation rates and its reasons were similar to the other
studies conducted in Pakistan[27–29] and in other settings[7,30].
These findings are not only important for the on-going social franchising program but also
at national level where the use of LARCmethods of contraception is negligible, and these meth-
ods have higher discontinuation rates with the most predominant identified reason being side
effects[16]. While it is important to give complete information to the family planning clients at
the time of service provision, our study highlighted that active post-insertion follow-up is likely
to enhance method continuation among LARC users, as well as facilitate clients to switch
methods in the case of unacceptable side effects. In addition, our study presented a more
resource-efficient follow-up strategy in the form of telephone-based follow-up, which was
found to be equally effective as a home-based visit. In this project, FHEs were paid 57 cents (1
USD = 104.7 PKR) and 96 cents (1 USD = 104.7 PKR) for telephone-based and home-based
follow-up, respectively—which clearly indicates that while telephone-based was equally effec-
tive, the cost is approximately 40% lower than a home-based visit. Hence, telephone-based fol-
low-up is expected to save time, energy and cost in contrast to a home-based approach.
Capitalising on the rapid increase in availability and use of mobile phones in the country[24],
telephone-based follow-up will certainly be a convenient way to enhance method continuity
for community health workers, be it FHE, Lady Health Worker, or any outreach worker who
has a mandate to provide follow-up to FP clients for side effect management. This approach
has the potential to reduce the amount of time and resources required for household visits—
especially in rural settings. Furthermore, telephone based follow up is expected to provide
CHWs as well as the users with a tool to cope with socio-cultural and geographical barriers
[23,31,32] that restrict their ability to provide or access services. Lastly, this approach may help
CHWs to protect the confidentiality of contraceptive users which could be compromised when
clients are visited in their homes—especially in cases where women conceal their contraceptive
use from other family members[33]. Above all, the unprecedented increase in the number of
users of cell phone and internet technology, as well as a decline in the price of devices and ser-
vices in developing countries[34–36] will increasingly facilitate programs to operationalize and
sustain this approach in resource limited settings. On the whole, these approaches could prove
most beneficial for improving method continuation and to ensure clients switch method in the
case of intolerable side effects, thus contributing to reducing unmet need for family planning
and unintended pregnancies. We encourage further research on cost-effectiveness of tele-
phone-based follow-up approach as opposed to home-based follow-up. Moreover, the fre-
quency of follow-up visits in this research was quite high, we propose further studies to
determine the ideal number and most appropriate timing of visit post method use keeping in
view of time when users are likely to experience side effect or discontinue the use of method.
Furthermore, our study provides information on other contraceptive behaviours. For exam-
ple, fairly similar proportions of women sought medical assistance for side effect management
across the three groups; interestingly, women in the active group were more likely to return to
the same provider (who did the insertion) but they also had higher continuation rates and rates
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of switching to an alternative method in the case of side effects. In order to strengthen this
aspect of continuation, we recommend further research to understand this phenomenon
empirically. In addition, the findings showed higher method switching among clients in an
active follow-up group compared with those who were in the passive group. It further substan-
tiates that the importance of active follow-up–not only being effective in lowering method dis-
continuation but promoting method switching which may prevent unintended pregnancy.
Method discontinuation as a result of husband and/or in-laws opposition was relatively higher
in the passive group than the active follow-up groups, this may be associated with the recruit-
ment process whereby participants were provided with options to choose the group they would
like be in–and, it is very likely that women who had concealed method use from their family
may have opted for passive group to protect confidentiality which may be at higher risk when
being proactively followed-up FHE.
Satisfaction reported was overwhelmingly high and should be interpreted with caution. In
our case, it may have been exacerbated due to strong relationship between FHE and clients that
might have fostered over time. Even though this issue was minimised by having external enu-
merators, we suggest more robust measure methods to be used in future. Moreover, because
the data were only collected at 12 month post insertion, chances of recall bias could not be
ruled out. There are some limitations to this study–in particular the recruitment of participants
to the three arms of the study was not randomised. This seems to have resulted in a high pro-
portion of women in the telephone group with implants, the reason being that implants were
only provided by the medical doctors who were based in the urban areas where communities
were affluent and had greater access to mobile phones. This may have affected the crude results
positively in favour of telephone-based group as implants have lower 12 month discontinua-
tion rates compared with intra-uterine device[28,37]. This was adjusted for in the multivariable
analyses; however, due to non-random allocation of study participants—many other observed
and unobserved characteristics may vary across the study groups.
Conclusion
Based on the findings, we conclude that the passive follow-up approach was found to be signifi-
cantly inferior to active follow-up in sustaining the continued use of LARC. In addition, within
active follow-up approaches, telephone-based follow-up was found to work equally well for
LARC continuation as home-based (gold standard) follow-up. We propose that in order to
enhance method continuity, LARC users should be actively followed-up especially in the criti-
cal post-insertion period. Also, telephone-based reminders could be used to both save
resources and allow women to be followed up in a manner that maintains their privacy regard-
ing family planning.
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